1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Biobanks Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Biobanks Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Biobanks Market Regional Analysis
6.2 Europe Biobanks Market Revenue 2019-2028 (US$ Million)
6.3 Europe Biobanks Market Forecast Analysis
7. Europe Biobanks Market Analysis – by Product and Service
7.1 Equipment
- 7.1.1 Overview
- 7.1.2 Equipment: Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Consumables
- 7.2.1 Overview
- 7.2.2 Consumables: Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Service
- 7.3.1 Overview
- 7.3.2 Service: Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Software
- 7.4.1 Overview
- 7.4.2 Software: Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Biobanks Market Analysis – by Sample
8.1 Blood Products
- 8.1.1 Overview
- 8.1.2 Blood Products: Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Human Tissues
- 8.2.1 Overview
- 8.2.2 Human Tissues: Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Cell Lines
- 8.3.1 Overview
- 8.3.2 Cell Lines: Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Biobanks Market Analysis – by Application
9.1 Regenerative Medicine
- 9.1.1 Overview
- 9.1.2 Regenerative Medicine: Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Life Science Research
- 9.2.1 Overview
- 9.2.2 Life Science Research: Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Clinical Research
- 9.3.1 Overview
- 9.3.2 Clinical Research : Europe Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Biobanks Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Biobanks Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Biobanks Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Biobanks Market Breakdown, by Product and Service
- 10.2.1.1.2 UK: Europe Biobanks Market Breakdown, by Sample
- 10.2.1.1.3 UK: Europe Biobanks Market Breakdown, by Application
- 10.2.1.2 Germany:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Biobanks Market Breakdown, by Product and Service
- 10.2.1.2.2 Germany: Europe Biobanks Market Breakdown, by Sample
- 10.2.1.2.3 Germany: Europe Biobanks Market Breakdown, by Application
- 10.2.1.3 France:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Biobanks Market Breakdown, by Product and Service
- 10.2.1.3.2 France: Europe Biobanks Market Breakdown, by Sample
- 10.2.1.3.3 France: Europe Biobanks Market Breakdown, by Application
- 10.2.1.4 Russia:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Biobanks Market Breakdown, by Product and Service
- 10.2.1.4.2 Russia: Europe Biobanks Market Breakdown, by Sample
- 10.2.1.4.3 Russia: Europe Biobanks Market Breakdown, by Application
- 10.2.1.5 Italy:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Biobanks Market Breakdown, by Product and Service
- 10.2.1.5.2 Italy: Europe Biobanks Market Breakdown, by Sample
- 10.2.1.5.3 Italy: Europe Biobanks Market Breakdown, by Application
- 10.2.1.6 Rest of Europe:
Europe Biobanks Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Biobanks Market Breakdown, by Product and Service
- 10.2.1.6.2 Rest of Europe: Europe Biobanks Market Breakdown, by Sample
- 10.2.1.6.3 Rest of Europe: Europe Biobanks Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Tecan Trading AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 QIAGEN
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Hamilton Company
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Avantor, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 MICRONICS JAPAN CO., LTD.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 BD
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Taylor-Wharton
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Brooks Automation, Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Promega Corporation
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 SciSafe Inc.
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Biovault Family
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations